Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.

Alsaad N, van Altena R, Pranger AD, van Soolingen D, de Lange WC, van der Werf TS, Kosterink JG, Alffenaar JW.

Eur Respir J. 2013 Aug;42(2):504-12. doi: 10.1183/09031936.00114812. Epub 2012 Oct 25.

2.

The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.

Palomino JC, Martin A.

Future Microbiol. 2016;11(4):539-47. doi: 10.2217/fmb.16.2. Epub 2016 Apr 12. Review.

PMID:
27070731
3.

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis.

Alsaad N, Wilffert B, van Altena R, de Lange WC, van der Werf TS, Kosterink JG, Alffenaar JW.

Eur Respir J. 2014 Mar;43(3):884-97. doi: 10.1183/09031936.00113713. Epub 2013 Aug 29. Review.

4.

Management of multidrug resistant tuberculosis.

Daley CL, Caminero JA.

Semin Respir Crit Care Med. 2013 Feb;34(1):44-59. doi: 10.1055/s-0032-1333546. Epub 2013 Mar 4. Review.

PMID:
23460005
5.

Drug-resistant tuberculosis: past, present, future.

Chiang CY, Centis R, Migliori GB.

Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19. Review.

PMID:
20337989
6.

New treatment options for multidrug-resistant tuberculosis.

Field SK, Fisher D, Jarand JM, Cowie RL.

Ther Adv Respir Dis. 2012 Oct;6(5):255-68. Epub 2012 Jul 4. Review.

PMID:
22763676
7.

Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.

Chahine EB, Karaoui LR, Mansour H.

Ann Pharmacother. 2014 Jan;48(1):107-15. doi: 10.1177/1060028013504087. Epub 2013 Nov 1. Review.

PMID:
24259600
8.

Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.

Chang KC, Yew WW.

Respirology. 2013 Jan;18(1):8-21. doi: 10.1111/j.1440-1843.2012.02257.x. Review.

9.

Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.

Martins M, Viveiros M, Couto I, Amaral L.

Int J Tuberc Lung Dis. 2009 May;13(5):569-73. Review.

PMID:
19383188
10.

Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.

Pranger AD, Alffenaar JW, Aarnoutse RE.

Curr Pharm Des. 2011;17(27):2900-30. Review.

PMID:
21834759
11.

Drug-resistant tuberculosis: an insurmountable epidemic?

Chakroborty A.

Inflammopharmacology. 2011 Jun;19(3):131-7. doi: 10.1007/s10787-010-0072-2. Epub 2010 Dec 3. Review.

PMID:
21127999
12.

Therapeutic drug monitoring in the treatment of tuberculosis: an update.

Alsultan A, Peloquin CA.

Drugs. 2014 Jun;74(8):839-54. doi: 10.1007/s40265-014-0222-8. Review. Erratum in: Drugs. 2014 Jun;74(9):2061. Dosage error in article text.

PMID:
24846578
13.

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.

Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM.

Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Review.

PMID:
21839855
14.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
15.

Mechanisms of drug resistance in Mycobacterium tuberculosis.

Zhang Y, Yew WW.

Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30. Review.

PMID:
19861002
16.

Drug treatment of multidrug-resistant osteoarticular tuberculosis: a systematic literature review.

Suárez-García I, Noguerado A.

Int J Infect Dis. 2012 Nov;16(11):e774-8. doi: 10.1016/j.ijid.2012.07.011. Epub 2012 Aug 30. Review.

17.

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.

Sotgiu G, Centis R, D'Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB.

Eur Respir J. 2012 Dec;40(6):1430-42. doi: 10.1183/09031936.00022912. Epub 2012 Apr 10. Review.

18.

Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis.

van der Paardt AF, Wilffert B, Akkerman OW, de Lange WC, van Soolingen D, Sinha B, van der Werf TS, Kosterink JG, Alffenaar JW.

Eur Respir J. 2015 Aug;46(2):444-55. doi: 10.1183/09031936.00147014. Epub 2015 May 28. Review.

19.

Global clinical trials for the treatment of TB with thioridazine.

Boeree MJ.

Recent Pat Antiinfect Drug Discov. 2011 May;6(2):99-103. Review.

PMID:
21548879
20.

Supplemental Content

Support Center